X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6613) 6613
Book Review (910) 910
Publication (265) 265
Newsletter (59) 59
Magazine Article (28) 28
Conference Proceeding (27) 27
Newspaper Article (16) 16
Book Chapter (14) 14
Dissertation (7) 7
Trade Publication Article (4) 4
Transcript (4) 4
Book / eBook (3) 3
Web Resource (3) 3
Archival Material (1) 1
Government Document (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4823) 4823
index medicus (4808) 4808
enoxaparin (4068) 4068
female (2760) 2760
male (2556) 2556
anticoagulants - therapeutic use (2002) 2002
middle aged (1851) 1851
enoxaparin - therapeutic use (1801) 1801
aged (1755) 1755
prevention (1476) 1476
venous thromboembolism (1470) 1470
molecular-weight heparin (1346) 1346
adult (1309) 1309
anticoagulants - administration & dosage (1201) 1201
enoxaparin - administration & dosage (1172) 1172
anticoagulants (1149) 1149
hematology (1134) 1134
treatment outcome (1091) 1091
anticoagulants - adverse effects (1083) 1083
unfractionated heparin (1050) 1050
abridged index medicus (1042) 1042
surgery (1023) 1023
thromboembolism (1016) 1016
heparin (982) 982
peripheral vascular disease (975) 975
risk factors (958) 958
enoxaparin - adverse effects (909) 909
deep-vein thrombosis (882) 882
thrombosis (826) 826
thromboprophylaxis (778) 778
cardiac & cardiovascular systems (741) 741
prophylaxis (730) 730
venous thromboembolism - prevention & control (715) 715
medicine, general & internal (698) 698
aged, 80 and over (670) 670
drug therapy (662) 662
pharmacology & pharmacy (658) 658
heparin, low-molecular-weight - therapeutic use (636) 636
venous thrombosis - prevention & control (634) 634
fibrinolytic agents - therapeutic use (586) 586
hemorrhage - chemically induced (563) 563
retrospective studies (560) 560
rivaroxaban (547) 547
prospective studies (531) 531
heparin - therapeutic use (517) 517
postoperative complications - prevention & control (507) 507
warfarin (492) 492
thromboembolism - prevention & control (481) 481
time factors (449) 449
risk (443) 443
medicine & public health (442) 442
therapy (442) 442
anticoagulation (420) 420
pulmonary-embolism (420) 420
venous thrombosis (413) 413
trial (412) 412
factor xa inhibitors (404) 404
enoxaparin - pharmacology (396) 396
anticoagulants - pharmacology (389) 389
double-blind (388) 388
low-molecular-weight heparin (385) 385
dose-response relationship, drug (383) 383
safety (382) 382
pulmonary embolism (380) 380
pregnancy (373) 373
care and treatment (372) 372
animals (371) 371
analysis (370) 370
fondaparinux (360) 360
management (356) 356
health aspects (355) 355
drug administration schedule (345) 345
low molecular weight heparin (345) 345
acute coronary syndromes (339) 339
pharmacokinetics (338) 338
risk assessment (337) 337
venous thromboembolism - etiology (337) 337
venous thrombosis - drug therapy (334) 334
heparin, low-molecular-weight - administration & dosage (330) 330
administration, oral (329) 329
dosage and administration (327) 327
randomized controlled trials as topic (326) 326
fibrinolytic agents - administration & dosage (324) 324
adolescent (320) 320
aspirin (317) 317
orthopedics (314) 314
myocardial infarction - drug therapy (313) 313
venous thrombosis - etiology (308) 308
mortality (307) 307
metaanalysis (303) 303
follow-up studies (298) 298
research (295) 295
drug therapy, combination (294) 294
double-blind method (292) 292
injections, subcutaneous (284) 284
pulmonary embolism - prevention & control (283) 283
efficacy (282) 282
arthroplasty (281) 281
heparin - adverse effects (280) 280
complications (279) 279
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6161) 6161
German (150) 150
Spanish (137) 137
French (114) 114
Russian (67) 67
Portuguese (25) 25
Italian (19) 19
Polish (18) 18
Korean (12) 12
Chinese (10) 10
Turkish (8) 8
Norwegian (7) 7
Czech (6) 6
Japanese (5) 5
Danish (4) 4
Serbian (4) 4
Ukrainian (4) 4
Persian (3) 3
Finnish (2) 2
Bulgarian (1) 1
Croatian (1) 1
Dutch (1) 1
Hebrew (1) 1
Hungarian (1) 1
Slovenian (1) 1
Swedish (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 06/2008, Volume 358, Issue 26, pp. 2765 - 2775
Rivaroxaban is an orally administered direct inhibitor of factor Xa. As compared with enoxaparin, rivaroxaban was more effective in preventing venous... 
ORAL XIMELAGATRAN | MEDICINE, GENERAL & INTERNAL | FACTOR-XA INHIBITOR | KNEE REPLACEMENT | BAY-59-7939 | DEEP-VENOUS THROMBOSIS | MOLECULAR-WEIGHT HEPARIN | MAJOR ORTHOPEDIC-SURGERY | DOUBLE-BLIND | PREVENTION | THROMBOEMBOLISM | Thiophenes - therapeutic use | Pulmonary Embolism - prevention & control | Venous Thromboembolism - mortality | Factor Xa Inhibitors | Thiophenes - adverse effects | Humans | Middle Aged | Male | Enoxaparin - therapeutic use | Pulmonary Embolism - epidemiology | Enoxaparin - adverse effects | Rivaroxaban | Venous Thromboembolism - prevention & control | Aged, 80 and over | Adult | Female | Venous Thrombosis - prevention & control | Morpholines - adverse effects | Morpholines - therapeutic use | Double-Blind Method | Anticoagulants - therapeutic use | Arthroplasty, Replacement, Hip | Anticoagulants - adverse effects | Venous Thrombosis - epidemiology | Adolescent | Aged | Enoxaparin | Dosage and administration | Blood coagulation factors | Comparative analysis | Health aspects | Hip joint | Clinical trials | Comparative studies | Joint surgery | Drug therapy | Clinical outcomes | Blood clots | Index Medicus | Abridged Index Medicus | Enoxaparin/adverse effects/therapeutic use | Venous Thrombosis/epidemiology/prevention & control | Thiophenes/adverse effects/therapeutic use | Arthroplasty | Replacement | Kirurgi | Hip | Morpholines/adverse effects/therapeutic use | 80 and over | Surgery | Anticoagulants/adverse effects/therapeutic use | Venous Thromboembolism/mortality/prevention & control | Factor Xa/antagonists & inhibitors | Pulmonary Embolism/epidemiology/prevention & control
Journal Article
by Büller, Harry R and Prins, Martin H and Lensin, Anthonie W. A and Decousus, Hervé and Jacobson, Barry F and Minar, Erich and Chlumsky, Jaromir and Verhamme, Peter and Wells, Phil and Agnelli, Giancarlo and Cohen, Alexander and Berkowitz, Scott D and Bounameaux, Henri and Davidson, Bruce L and Misselwitz, Frank and Gallus, Alex S and Raskob, Gary E and Schellong, Sebastian and Segers, Annelise and Berkowitz, Scott and Gallus, Alexander and Lensing, Anthonie W. A and Haskell, Lloyd and Raskob, Gary and Bauersachs, Rupert and van Bellen, Bonno and Boda, Zoltán and Borris, Lars and Brenner, Benjamin and Brighton, Tim and Davidson, Bruce and Decousus, Herve and Eriksson, Henry and Jacobson, Barry and Kakkar, Ajay and Kwong, Yok-Lam and Lee, Lai Heng and Meijer, Karina and van der Meer, Jan and Monreal, Manuel and Piovella, Franco and Sandset, Per Morten and Smith, Mark and Tomkowski, Witold and Wang, Yuqi and Brandjes, Dees and Mac Gillavry, Melvin and Otten, Hans-Martin and Carlsson, Anders and Laporte, Silvy and Schulman, Sam and Gent, Michael and Turpie, Alexander and Martinelli, Ida and Lensing, Anthonie W and Muhlhofer, Eva and Tewes, Miriam and Trajanovic, Mila and Muller, Karin and Kim, Calvin and Gebel, Martin and Benson, Alice and Pap, Akos Ferenc and Goie, Juliette and Horvat-Broecker, Anea and Spadari, Giovanni and Peters-Wulf, Cornelia and Roig, J and Baker, R and Bianchi, A and Blombery, P and Brighton, T and Campbell, P and Carroll, P and Geraghty, R and Chong, B and Ramanathan, S and Archis, C and Coughlin, P and Salem, H and Crispin, P and Dean, M and Soni, R and Denaro, C and Kubler, P and Coghlan, D and Gallus, A and Gan, T. Eng and Tran, H and Coleman, C and Jackson, D and Khalafallah, A and Leahy, M and Leyden, M and Leyden, D and Sturtz, C and McCann, A and Gibbs, H and McRae, S and Richards, B and ... and The EINSTEIN–PE Investigators and EINSTEIN-PE Investigators and EINSTEIN–PE Investigators
The New England Journal of Medicine, ISSN 0028-4793, 04/2012, Volume 366, Issue 14, pp. 1287 - 1297
Journal Article
Lancet, The, ISSN 0140-6736, 2008, Volume 372, Issue 9632, pp. 31 - 39
Summary Background The risk of venous thromboembolism is high after total hip arthroplasty and could persist after hospital discharge. Our aim was to compare... 
Internal Medicine | WEIGHT HEPARIN-PROPHYLAXIS | MEDICINE, GENERAL & INTERNAL | PLACEBO | FACTOR-XA INHIBITOR | ORTHOPEDIC-SURGERY | KNEE REPLACEMENT | BAY-59-7939 | THROMBOSIS | PROLONGED THROMBOPROPHYLAXIS | TIME-COURSE | DALTEPARIN | Thiophenes - therapeutic use | Double-Blind Method | Drug Administration Schedule | Thiophenes - adverse effects | Humans | Middle Aged | Morpholines - administration & dosage | Arthroplasty, Replacement, Hip | Male | Thiophenes - administration & dosage | Enoxaparin - therapeutic use | Enoxaparin - adverse effects | Fibrinolytic Agents - adverse effects | Rivaroxaban | Venous Thromboembolism - prevention & control | Enoxaparin - administration & dosage | Fibrinolytic Agents - therapeutic use | Aged, 80 and over | Adult | Female | Aged | Fibrinolytic Agents - administration & dosage | Morpholines - adverse effects | Morpholines - therapeutic use | Health care | Medical imaging | Hospitals | Protease inhibitors | Surgery | Tomography | Joint surgery | Drug therapy | Patients | Veins & arteries | Index Medicus | Abridged Index Medicus | Thiophenes/administration & dosage/adverse effects/therapeutic use | use | Arthroplasty | Replacement | Venous Thromboembolism/prevention & control | Morpholines/administration & dosage/adverse effects/therapeutic use | Kirurgi | Hip | 80 and over | Enoxaparin/administration & dosage/adverse effects/therapeutic use | Fibrinolytic Agents/administration & dosage/adverse effects/therapeutic
Journal Article
by Büller, Harry R and Décousus, Hervé and Grosso, Michael A and Mercuri, Michele and Middeldorp, Saskia and Prins, Martin H and Raskob, Gary E and Schellong, Sebastian M and Schwocho, Lee and Segers, Annelise and Shi, Minggao and Verhamme, Peter and Wells, Phil and Agnelli, Giancarlo and Angchaisuksiri, Pantep and Banyai, Martin and Bauersachs, Rupert and van Bellen, Bonno and Blüguermann, Julio and Boda, Zoltán and Bounameaux, Henri and Brenner, Benjamin and Brighton, Tim and Castañon, Javier Diaz and Chechulov, Pavel and Chlumský, Yaromir and Cohen, Alexander and Davidson, Bruce and Decousus, Hervé and Eriksson, Henry and Gallus, Alexander and Gudz, Ivan and Jacobson, Barry and Heng, Lee Lai and Lyons, Roger and Meijer, Karina and Minar, Erich and Monreal, Manuel and Nakamura, Mashio and Oh, Doyeun and Öngen, Gül and Parakh, Rajiv and Piovella, Franco and Raskob, Gary and Rehm, Jeffery and Sandset, Per Morten and Schellong, Sebastian and Smith, Mark and Sokurenko, German and Tomkowski, Witold and Torp-Pedersen, Christian and Wang, Chen and Wang, Yuqi and Weitz, Jeff and Yanushko, Vyacheslav and Yin, Wei-Hsian and Prins, Martin and Beenen, Ludo and Brandjes, Dees and MacGillavry, Melvin and Kaplowitz, Neil and Otten, Hans-Martin and Pessayre, Dominique and Peters, Ron and Roos, Yvo and Slagboom, Ton and Eikelboom, John and Crowther, Mark and Roberts, Robin and Vanassche, Thomas and Vandenbriele, Christophe and Debaveye, Barbara and Dani, Viddhi and van Bergen, Petro and Gerrits, Paul and van Kranen, Robbert and Lanz, Hans and Grosso, Michael and Kappelhoff, John and Franc, John and Zhang, George and Lin, Min and Crerand, William and Giordano, Chris and Skinner, Maureen and Hurley, Steve and Lovelace, Gregg and Barrier, Robert and Betcher, Josh and Alvarez, C and Amuchastegui, L. M and Blüguermann, J and Cassettari, A and Ceressetto, J and Hrabar, NN and Macin, S and Mahuad, C and Oberti, P and Santini, F and Baker, R. I and ... and The Hokusai-VTE Investigators and Hokusai-VTE Investigators
The New England Journal of Medicine, ISSN 0028-4793, 10/2013, Volume 369, Issue 15, pp. 1406 - 1415
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 01/2009, Volume 101, Issue 1, pp. 77 - 85